| NCT06150664 | A Phase 1 of CTX-8371 in Patients With Advanced Malignancies | RECRUITING | PHASE1 | 2024-03-19 | 2026-04 | 2025-10 |
| NCT05506943 | A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) | ACTIVE_NOT_RECRUITING | PHASE2, PHASE3 | 2023-01-09 | 2025-12 | 2025-07 |
| NCT05513742 | A Study of CTX-009 in Adult Patients With Metastatic Colorectal Cancer | COMPLETED | PHASE2 | 2022-12-08 | 2025-05-15 | 2025-04-28 |
| NCT03881488 | Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies | COMPLETED | PHASE1 | 2019-05-17 | 2025-05-21 | 2025-05-21 |